HEADER    ANTIBIOTIC                              23-JUL-97   1SHO              
TITLE     CRYSTAL STRUCTURE OF VANCOMYCIN AT ATOMIC RESOLUTION                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: VANCOMYCIN;                                                
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: AMYCOLATOPSIS ORIENTALIS;                       
SOURCE   4 ORGANISM_TAXID: 31958                                                
KEYWDS    GLYCOPEPTIDE, ANTIBIOTIC                                              
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    G.M.SHELDRICK                                                         
REVDAT   5   29-JUL-20 1SHO    1       COMPND REMARK SEQRES HETNAM              
REVDAT   5 2                   1       LINK   SITE   ATOM                       
REVDAT   4   27-JUL-11 1SHO    1       REMARK                                   
REVDAT   3   13-JUL-11 1SHO    1       VERSN                                    
REVDAT   2   24-FEB-09 1SHO    1       VERSN                                    
REVDAT   1   24-DEC-97 1SHO    0                                                
JRNL        AUTH   M.SCHAFER,T.R.SCHNEIDER,G.M.SHELDRICK                        
JRNL        TITL   CRYSTAL STRUCTURE OF VANCOMYCIN.                             
JRNL        REF    STRUCTURE                     V.   4  1509 1996              
JRNL        REFN                   ISSN 0969-2126                               
JRNL        PMID   8994975                                                      
JRNL        DOI    10.1016/S0969-2126(96)00156-6                                
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.09 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-96                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.09                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 70.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.3                           
REMARK   3   CROSS-VALIDATION METHOD           : NULL                           
REMARK   3   FREE R VALUE TEST SET SELECTION   : NULL                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : NULL                   
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.105                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 11867                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : NULL                   
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.104                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 11394                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 160                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 48                                            
REMARK   3   SOLVENT ATOMS      : 108                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 314.50                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 155.00                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 2                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 2867                    
REMARK   3   NUMBER OF RESTRAINTS                     : 3022                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.024                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.000                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.022                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.057                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.093                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.000                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.041                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.003                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.017                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.104                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228        
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : NULL                                
REMARK   3   SPECIAL CASE: ENGH AND HUBER RESTRAINT DISTANCES FOR ACETATE AND   
REMARK   3                 FOR THE TWO DISORDERED SUGARS                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1SHO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                
REMARK 100 THE DEPOSITION ID IS D_1000176377.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 29-AUG-95                          
REMARK 200  TEMPERATURE           (KELVIN) : 125                                
REMARK 200  PH                             : 5.8                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : EMBL/DESY, HAMBURG                 
REMARK 200  BEAMLINE                       : BW7B                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.862                              
REMARK 200  MONOCHROMATOR                  : GE(111)                            
REMARK 200  OPTICS                         : BENT CRYSTAL MONOCHROMATOR         
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 11867                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.090                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 70.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.3                               
REMARK 200  DATA REDUNDANCY                : 13.90                              
REMARK 200  R MERGE                    (I) : 0.05800                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 27.0000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.09                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.17                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 6.80                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.08300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 19.70                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: NULL                                           
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO                    
REMARK 200 SOFTWARE USED: SHELX-96                                              
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 57.61                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.8                                   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2                        
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z+1/2                                             
REMARK 290       3555   -Y+1/2,X+1/2,Z+3/4                                      
REMARK 290       4555   Y+1/2,-X+1/2,Z+1/4                                      
REMARK 290       5555   -X+1/2,Y+1/2,-Z+3/4                                     
REMARK 290       6555   X+1/2,-Y+1/2,-Z+1/4                                     
REMARK 290       7555   Y,X,-Z                                                  
REMARK 290       8555   -Y,-X,-Z+1/2                                            
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       32.91500            
REMARK 290   SMTRY1   3  0.000000 -1.000000  0.000000       14.24000            
REMARK 290   SMTRY2   3  1.000000  0.000000  0.000000       14.24000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       49.37250            
REMARK 290   SMTRY1   4  0.000000  1.000000  0.000000       14.24000            
REMARK 290   SMTRY2   4 -1.000000  0.000000  0.000000       14.24000            
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       16.45750            
REMARK 290   SMTRY1   5 -1.000000  0.000000  0.000000       14.24000            
REMARK 290   SMTRY2   5  0.000000  1.000000  0.000000       14.24000            
REMARK 290   SMTRY3   5  0.000000  0.000000 -1.000000       49.37250            
REMARK 290   SMTRY1   6  1.000000  0.000000  0.000000       14.24000            
REMARK 290   SMTRY2   6  0.000000 -1.000000  0.000000       14.24000            
REMARK 290   SMTRY3   6  0.000000  0.000000 -1.000000       16.45750            
REMARK 290   SMTRY1   7  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY2   7  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   8  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY2   8 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000       32.91500            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 730 ANGSTROM**2                           
REMARK 350 SURFACE AREA OF THE COMPLEX: 1650 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.2 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH A2035  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH B2016  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH B2017  LIES ON A SPECIAL POSITION.                          
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS              
REMARK 400  A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS          
REMARK 400  FURTHER GLYCOSYLATED BY A DISACCHARIDE MADE OF D-GLUCOSE            
REMARK 400  AND VANCOSAMINE.                                                    
REMARK 400  HERE, VANCOMYCIN IS REPRESENTED BY GROUPING TOUGHER THE             
REMARK 400  SEQUENCE (SEQRES) AND THE TWO LIGANDS (HET) BGC AND RER.            
REMARK 400                                                                      
REMARK 400 THE VANCOMYCIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS.        
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: VANCOMYCIN                                                   
REMARK 400   CHAIN: A, B, C, D                                                  
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   COMPONENT_2: RESIDUE BGC                                           
REMARK 400   COMPONENT_3: RESIDUE RER                                           
REMARK 400   DESCRIPTION: VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED  
REMARK 400                BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4.    
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A   3      -69.71   -101.95                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1AA5   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN                                      
REMARK 900 RELATED ID: 1C0Q   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH 2-ACETOXY-D-          
REMARK 900 PROPANOIC ACID                                                       
REMARK 900 RELATED ID: 1C0R   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN WITH D-LACTIC ACID                   
REMARK 900 RELATED ID: 1FVM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH DI-ACETYL-LYS-D-ALA-  
REMARK 900 D-ALA                                                                
REMARK 900 RELATED ID: 1GAC   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF A82846B COMPLEXED WITH ITS CELL WALL           
REMARK 900 PENTAPEPTIDE FRAGMENT                                                
REMARK 900 RELATED ID: 1GHG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON                              
REMARK 900 RELATED ID: 1PN3   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXD   
REMARK 900 WITH TDP AND DESVANCOSAMINYL VANCOMYCIN                              
REMARK 900 RELATED ID: 1PNV   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXED  
REMARK 900 WITH TDP AND VANCOMYCIN                                              
REMARK 900 RELATED ID: 1QD8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH N-ACETYL GLYCIN       
REMARK 900 RELATED ID: 1RRV   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TDP-VANCOSAMINYLTRANSFERASE GTFD COMPLEXED      
REMARK 900 WITH TDP AND DESVANCOSAMINYL VANCOMYCIN.                             
DBREF  1SHO A    1     7  NOR    NOR00681 NOR00681         1      7             
DBREF  1SHO B    1     7  NOR    NOR00681 NOR00681         1      7             
SEQRES   1 A    7  MLU OMZ ASN GHP GHP OMY 3FG                                  
SEQRES   1 B    7  MLU OMZ ASN GHP GHP OMY 3FG                                  
HET    MLU  A   1       9                                                       
HET    OMZ  A   2      14                                                       
HET    GHP  A   4      11                                                       
HET    GHP  A   5      11                                                       
HET    OMY  A   6      14                                                       
HET    3FG  A   7      13                                                       
HET    MLU  B   1       9                                                       
HET    OMZ  B   2      14                                                       
HET    GHP  B   4      11                                                       
HET    GHP  B   5      11                                                       
HET    OMY  B   6      14                                                       
HET    3FG  B   7      13                                                       
HET    BGC  C   1      11                                                       
HET    RER  C   2      11                                                       
HET    BGC  D   1      12                                                       
HET    RER  D   2      10                                                       
HET    ACT  B  10       4                                                       
HET     CL  B  11       1                                                       
HET     CL  B  12       1                                                       
HETNAM     MLU N-METHYL-D-LEUCINE                                               
HETNAM     OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE                         
HETNAM     GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID                         
HETNAM     OMY (BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE                         
HETNAM     3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID                     
HETNAM     BGC BETA-D-GLUCOPYRANOSE                                             
HETNAM     RER VANCOSAMINE                                                      
HETNAM     ACT ACETATE ION                                                      
HETNAM      CL CHLORIDE ION                                                     
HETSYN     RER VANCOSAMINE                                                      
FORMUL   1  MLU    2(C7 H15 N O2)                                               
FORMUL   1  OMZ    2(C9 H10 CL N O4)                                            
FORMUL   1  GHP    4(C8 H9 N O3)                                                
FORMUL   1  OMY    2(C9 H10 CL N O4)                                            
FORMUL   1  3FG    2(C8 H9 N O4)                                                
FORMUL   3  BGC    2(C6 H12 O6)                                                 
FORMUL   3  RER    2(C7 H15 N O3)                                               
FORMUL   5  ACT    C2 H3 O2 1-                                                  
FORMUL   6   CL    2(CL 1-)                                                     
FORMUL   8  HOH   *108(H2 O)                                                    
LINK         C   MLU A   1                 N   OMZ A   2     1555   1555  1.34  
LINK         C   OMZ A   2                 N   ASN A   3     1555   1555  1.31  
LINK         OH  OMZ A   2                 C5  GHP A   4     1555   1555  1.39  
LINK         C   ASN A   3                 N   GHP A   4     1555   1555  1.33  
LINK         C   GHP A   4                 N   GHP A   5     1555   1555  1.33  
LINK         C3  GHP A   4                 OCZ OMY A   6     1555   1555  1.40  
LINK         O4  GHP A   4                 C1  BGC C   1     1555   1555  1.39  
LINK         C   GHP A   5                 N   OMY A   6     1555   1555  1.32  
LINK         C3  GHP A   5                 CG1 3FG A   7     1555   1555  1.50  
LINK         C   OMY A   6                 N   3FG A   7     1555   1555  1.32  
LINK         C   MLU B   1                 N   OMZ B   2     1555   1555  1.32  
LINK         C   OMZ B   2                 N   ASN B   3     1555   1555  1.31  
LINK         OH  OMZ B   2                 C5  GHP B   4     1555   1555  1.38  
LINK         C   ASN B   3                 N   GHP B   4     1555   1555  1.32  
LINK         C   GHP B   4                 N   GHP B   5     1555   1555  1.33  
LINK         C3  GHP B   4                 OCZ OMY B   6     1555   1555  1.42  
LINK         O4  GHP B   4                 C1  BGC D   1     1555   1555  1.37  
LINK         C   GHP B   5                 N   OMY B   6     1555   1555  1.34  
LINK         C3  GHP B   5                 CG1 3FG B   7     1555   1555  1.47  
LINK         C   OMY B   6                 N   3FG B   7     1555   1555  1.33  
LINK         O2  BGC C   1                 C1  RER C   2     1555   1555  1.44  
LINK         O2  BGC D   1                 C1  RER D   2     1555   1555  1.43  
CISPEP   1 GHP A    5    OMY A    6          0         5.48                     
CISPEP   2 GHP B    5    OMY B    6          0        18.56                     
CRYST1   28.480   28.480   65.830  90.00  90.00  90.00 P 43 21 2    16          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.035112  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.035112  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.015191        0.00000                         
HETATM    1  N   MLU A   1       4.206   5.428  -4.101  1.00  5.74           N  
ANISOU    1  N   MLU A   1      643    827    658     -3   -107      0       N  
HETATM    2  CN  MLU A   1       3.894   4.079  -4.705  1.00  8.50           C  
ANISOU    2  CN  MLU A   1      936   1010   1204   -105   -280   -264       C  
HETATM    3  CA  MLU A   1       5.454   5.454  -3.281  1.00  4.89           C  
ANISOU    3  CA  MLU A   1      579    734    499    -11    -12     -3       C  
HETATM    4  C   MLU A   1       6.637   5.024  -4.166  1.00  4.56           C  
ANISOU    4  C   MLU A   1      648    637    404     15    -28     -3       C  
HETATM    5  O   MLU A   1       6.830   5.601  -5.199  1.00  6.55           O  
ANISOU    5  O   MLU A   1      951    912    566    218    116    189       O  
HETATM    6  CB  MLU A   1       5.707   6.851  -2.754  1.00  5.06           C  
ANISOU    6  CB  MLU A   1      613    692    570     18     17    -43       C  
HETATM    7  CG  MLU A   1       4.648   7.460  -1.857  1.00  5.81           C  
ANISOU    7  CG  MLU A   1      714    786    654     26     52    -59       C  
HETATM    8  CD1 MLU A   1       4.334   6.632  -0.621  1.00 10.02           C  
ANISOU    8  CD1 MLU A   1     1572   1208    934    129    564    135       C  
HETATM    9  CD2 MLU A   1       5.068   8.880  -1.492  1.00  7.96           C  
ANISOU    9  CD2 MLU A   1     1083    838   1027     78     76   -247       C  
HETATM   10  N   OMZ A   2       7.401   4.022  -3.709  1.00  3.96           N  
ANISOU   10  N   OMZ A   2      555    564    348    -56    -31    -40       N  
HETATM   11  CA  OMZ A   2       8.462   3.511  -4.534  1.00  4.05           C  
ANISOU   11  CA  OMZ A   2      581    515    404    -26    -72    -64       C  
HETATM   12  C   OMZ A   2       9.777   4.294  -4.399  1.00  3.88           C  
ANISOU   12  C   OMZ A   2      581    503    353    -52    -11    -30       C  
HETATM   13  O   OMZ A   2      10.749   3.982  -5.111  1.00  4.67           O  
ANISOU   13  O   OMZ A   2      696    667    369    -59     58   -179       O  
HETATM   14  CB  OMZ A   2       8.762   1.989  -4.291  1.00  4.47           C  
ANISOU   14  CB  OMZ A   2      728    456    471    -71    -98    -76       C  
HETATM   15  OC  OMZ A   2       7.555   1.246  -4.420  1.00  5.20           O  
ANISOU   15  OC  OMZ A   2      753    597    575   -113   -174    -55       O  
HETATM   16  CG  OMZ A   2       9.431   1.715  -2.996  1.00  4.61           C  
ANISOU   16  CG  OMZ A   2      748    461    500      4   -133   -104       C  
HETATM   17  CD1 OMZ A   2      10.795   1.482  -2.957  1.00  5.15           C  
ANISOU   17  CD1 OMZ A   2      767    552    591    -17    -86    -99       C  
HETATM   18  CD2 OMZ A   2       8.716   1.717  -1.788  1.00  4.84           C  
ANISOU   18  CD2 OMZ A   2      750    534    508    -41   -121    -12       C  
HETATM   19  CE1 OMZ A   2      11.457   1.293  -1.770  1.00  5.60           C  
ANISOU   19  CE1 OMZ A   2      832    585    660    -60   -215    -63       C  
HETATM   20 CL   OMZ A   2      13.103   0.919  -1.739  1.00  9.81          CL  
ANISOU   20 CL   OMZ A   2     1002   1413   1219     75   -294   -148      CL  
HETATM   21  CE2 OMZ A   2       9.406   1.572  -0.579  1.00  5.05           C  
ANISOU   21  CE2 OMZ A   2      913    468    490    -47   -152     30       C  
HETATM   22  CZ  OMZ A   2      10.768   1.393  -0.575  1.00  5.37           C  
ANISOU   22  CZ  OMZ A   2      958    445    586    -85   -284     67       C  
HETATM   23  OH  OMZ A   2      11.418   1.333   0.643  1.00  5.72           O  
ANISOU   23  OH  OMZ A   2     1033    455    632    -91   -299     68       O